Common Fund For Nonprofit Organizations Ngm Biopharmaceuticals Inc Transaction History

Common Fund For Nonprofit Organizations

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Aug 13, 2024	SELL	$12.59 - $17.67 $223,157 - $313,200	-17,725 Closed	0 $0
Q2 2022 Aug 13, 2024	BUY	$10.58 - $17.5 $187,530 - $310,187	17,725 New	17,725 $227 Million

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Common Fund For Nonprofit Organizations, based on Form 13F filings with the SEC.

Stay updated on Common Fund For Nonprofit Organizations with notifications on news.